Trial Profile
Efficacy of sofosbuvir and ribavirin therapy in patients with genotype 2 hepatitis C virus: Significance of variants associated with resistance in NS3, NS5A and NS5B region
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Jul 2020
Price :
$35
*
At a glance
- Drugs Sofosbuvir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 04 Jul 2020 Status changed from active, no longer recruiting to completed.
- 28 Dec 2019 Status changed from recruiting to active, no longer recruiting.
- 06 Jul 2015 New trial record